SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in SpringWorks Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 144
- +3 vs. Q3 2021
- Shares held
- 45.5M
- +540.5K (+1.2%) vs. Q3 2021
- Total value
- $2.82B
- −$32.8M (−1.2%) vs. Q3 2021
- New holders
- 19
- 61 more added
- Sold out
- 16
- 43 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $47 |
| Q1 2026 | 1 | $47 |
| Q4 2025 | 2 | $2.18M |
| Q3 2025 | 3 | $2.16M |
| Q2 2025 | 223 | $3.65B |
| Q1 2025 | 306 | $3.29B |
| Q4 2024 | 216 | $2.92B |
| Q3 2024 | 226 | $2.59B |
| Q2 2024 | 209 | $2.91B |
| Q1 2024 | 217 | $3.85B |
| Q4 2023 | 180 | $2.75B |
| Q3 2023 | 147 | $1.58B |
| Q2 2023 | 142 | $1.82B |
| Q1 2023 | 149 | $1.70B |
| Q4 2022 | 137 | $1.73B |
| Q3 2022 | 148 | $1.80B |
| Q2 2022 | 144 | $1.36B |
| Q1 2022 | 136 | $2.79B |
| Q4 2021 | 144 | $2.82B |
| Q3 2021 | 142 | $2.86B |
| Q2 2021 | 135 | $3.69B |
| Q1 2021 | 137 | $3.23B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding SpringWorks Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 88,275 | $5.47M | 0.00% | −24,961−22.0% | Reduced |
| Ensign Peak Advisors, Inc | 102,780 | $6.37M | 0.01% | +20,619+25.1% | Added |
| Deutsche Bank AG | 106,251 | $6.58M | 0.00% | −6,877−6.1% | Reduced |
| AXA S.A. | 109,100 | $6.76M | 0.02% | +1,304+1.2% | Added |
| Bank of New York Mellon Corp | 117,125 | $7.26M | 0.00% | +769+0.7% | Added |
| Nuveen Asset Management, LLC | 109,710 | $7.34M | 0.00% | −9,233−7.8% | Reduced |
| Samsara BioCapital, LLC | 140,267 | $8.69M | 1.73% | −29,585−17.4% | Reduced |
| Candriam Luxembourg S.C.A. | 172,556 | $10.7M | 0.07% | +31,722+22.5% | Added |
| Laurion Capital Management LP | 185,261 | $11.5M | 0.20% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 185,681 | $11.5M | 0.01% | +84,052+82.7% | Added |
| Charles Schwab Investment Management Inc | 191,259 | $11.9M | 0.00% | +3,029+1.6% | Added |
| Dimensional Fund Advisors LP | 192,243 | $11.9M | 0.00% | −3,593−1.8% | Reduced |
| Ameriprise Financial Inc | 195,727 | $12.1M | 0.00% | −1,167−0.6% | Reduced |
| Goldman Sachs Group Inc | 222,307 | $13.8M | 0.00% | +4,944+2.3% | Added |
| Bessemer Group Inc | 241,337 | $15.0M | 0.03% | 00.0% | Unchanged |
| Woodline Partners LP | 242,400 | $15.0M | 0.22% | +229,074+1,719.0% | Added |
| Affinity Asset Advisors, LLC | 298,545 | $18.5M | 7.89% | +172,532+136.9% | Added |
| Northern Trust Corp | 301,533 | $18.7M | 0.00% | +694+0.2% | Added |
| Phoenix Holdings Ltd. | 308,756 | $19.1M | 0.32% | +211,141+216.3% | Added |
| Price T Rowe Associates Inc | 312,041 | $19.3M | 0.00% | +4,634+1.5% | Added |
| Sphera Funds Management Ltd. | 342,566 | $21.2M | 2.52% | +94,649+38.2% | Added |
| Lord, Abbett & Co. LLC | 379,007 | $23.5M | 0.05% | +25,091+7.1% | Added |
| Massachusetts Financial Services Co | 384,705 | $23.8M | 0.01% | −2,919−0.8% | Reduced |
| Marshall Wace, LLP | 407,519 | $25.3M | 0.05% | +386,626+1,850.5% | Added |
| Deerfield Management Company, L.P. (Series C) | 452,000 | $28.0M | 0.59% | −58,673−11.5% | Reduced |
| Geode Capital Management, LLC | 492,338 | $30.5M | 0.00% | +4,902+1.0% | Added |
| Loomis Sayles & Co L P | 542,316 | $33.6M | 0.04% | −14,624−2.6% | Reduced |
| Norges Bank | 573,781 | $35.6M | 0.01% | +77,438+15.6% | Added |
| Adage Capital Partners GP, L.L.C. | 576,452 | $35.7M | 0.06% | −189,466−24.7% | Reduced |
| Fiera Capital Corp | 650,413 | $40.3M | 0.09% | +314,311+93.5% | Added |
| Pictet Asset Management SA | 693,655 | $43.0M | 0.04% | +325,706+88.5% | Added |
| Victory Capital Management Inc | 774,274 | $48.0M | 0.04% | −54,911−6.6% | Reduced |
| Artal Group S.A. | 850,000 | $52.7M | 1.55% | +250,000+41.7% | Added |
| ArrowMark Colorado Holdings LLC | 1,109,758 | $68.8M | 0.55% | +6,554+0.6% | Added |
| State Street Corp | 1,319,111 | $81.8M | 0.00% | −10,307−0.8% | Reduced |
| Bank of America Corp | 1,514,373 | $93.9M | 0.01% | +374,608+32.9% | Added |
| Driehaus Capital Management LLC | 1,787,902 | $110.8M | 1.13% | +152,755+9.3% | Added |
| Boxer Capital, LLC | 2,075,905 | $128.7M | 5.12% | 00.0% | Unchanged |
| BlackRock Inc. | 2,361,652 | $146.4M | 0.00% | −79,526−3.3% | Reduced |
| Vanguard Group Inc | 2,862,312 | $177.4M | 0.00% | +1540.0% | Added |
| FMR LLC | 3,946,320 | $244.6M | 0.02% | −68,800−1.7% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 4,831,307 | $299.4M | 23.75% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 4,849,912 | $300.6M | 4.64% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 6,028,307 | $373.6M | 4.85% | 00.0% | Unchanged |
| Jennison Associates LLC | 0 | $0 | 0.00% | −645,521−100.0% | Sold out |
| Consonance Capital Management LP | 0 | $0 | 0.00% | −305,994−100.0% | Sold out |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −196,912−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −112,643−100.0% | Sold out |
| Castleark Management LLC | 0 | $0 | 0.00% | −89,086−100.0% | Sold out |
| CastleArk Alternatives, LLC | 0 | $0 | 0.00% | −89,086−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −56,766−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −53,610−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −33,400−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −7,258−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −6,507−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −1,255−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,130−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −797−100.0% | Sold out |
| Red Tortoise LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |